ReviewFrontiers in immunology2023

T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.

Alexandre E Nowill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.